Pharmacy Online

Belkins
Pharmacy Online began its Internet presence in 1998, building on 40 years of retail pharmacy experience. Since 1966, the owners of Pharmacy Online have been providing their customers with quality advice, the lowest prices and highly responsive customer service. We are 100% Australian owned and continues to offer the lowest prices and highest service levels both online and in-store. Pharmacy Online goes further than just operating under the Australian Laws and Standards. In 2003, we were accredited by the Pharmacy Guild of Australia. Pharmacy Online is one of the few online pharmacies to have achieved accreditation under the Quality Care Pharmacy Program.

Related News

PHASE 1 CLINICAL TRIAL FOR CORONAVIRUS VACCINE BEGINS IN SEATTLE

PharmaNewsIntelligence | March 17, 2020

news image

Phase 1 clinical trials for a coronavirus vaccine have begun at Kaiser Permanente Washington Health Research Institute (KPWHR) has begun, according to a statement from the National Institutes of Health. The investigational vaccination, funded in part by the National Institute of Allergy and Infectious Disease, began today by administering the first immunization to a healthy adult between ages 18 and 55 years old. In total, the phase 1 clinical trial will enroll 45 adults who fit this criteria an...

Read More

RESEARCH

MINDMED SIGNS PARTNERSHIP WITH SWISS PSYCHEDELIC DRUG DISCOVERY STARTUP MINDSHIFT COMPOUNDS AG

MindMed | February 15, 2021

news image

MindMed, a leading psychedelic medicine biotech company announced another partnership with Swiss startup MindShift Compounds AG to develop and patent next-gen psychedelic compounds with psychedelic or empathogenic properties. As a component of this partnership, MindMed and MindShift Compounds AG have agreed to develop next-gen psychedelic and empathogenic substances together. The first initial compounds have just been combined by MindShift Compounds AG and related patent applicati...

Read More

PHARMACY MARKET

YANGTZE RIVER PHARMACEUTICAL GROUP SELECTS TRACELINK PLATFORM FOR GLOBAL COMPLIANCE

Yangtze River Pharmaceutical, TraceLink | May 06, 2021

news image

TraceLink Inc., the leading digital network platform company, today announced that Yangtze River Pharmaceutical Group has selected TraceLink's global compliance solution to aid its plans for global growth. As the company gears up for international market expansion this year, Yangtze River Pharmaceutical Group (YRPG) will use TraceLink's multienterprise compliance applications and industry-leading digital supply network to comply with track and trace requirements in multiple markets, incl...

Read More

CPD AND LEARNING

POSTERA AND NEUROLUCENT PARTNERS ON IDENTIFYING SMALL-MOLECULE THERAPEUTICS FOR ALZHEIMER'S DISEASE

PostEra | November 27, 2020

news image

PostEra, a biotechnology organization offering restorative science fueled by AI, today reported a joint effort with NeuroLucent, a Chicago-put together organization centered with respect to creating novel medicines for Alzheimer's sickness and different dementias. The disappointment of late-stage clinical preliminaries to reveal viable treatments for Alzheimer's illness has underscored the need to investigate novel helpful methodologies. NeuroLucent is creating novel littl...

Read More
news image

PHASE 1 CLINICAL TRIAL FOR CORONAVIRUS VACCINE BEGINS IN SEATTLE

PharmaNewsIntelligence | March 17, 2020

Phase 1 clinical trials for a coronavirus vaccine have begun at Kaiser Permanente Washington Health Research Institute (KPWHR) has begun, according to a statement from the National Institutes of Health. The investigational vaccination, funded in part by the National Institute of Allergy and Infectious Disease, began today by administering the first immunization to a healthy adult between ages 18 and 55 years old. In total, the phase 1 clinical trial will enroll 45 adults who fit this criteria an...

Read More
news image

RESEARCH

MINDMED SIGNS PARTNERSHIP WITH SWISS PSYCHEDELIC DRUG DISCOVERY STARTUP MINDSHIFT COMPOUNDS AG

MindMed | February 15, 2021

MindMed, a leading psychedelic medicine biotech company announced another partnership with Swiss startup MindShift Compounds AG to develop and patent next-gen psychedelic compounds with psychedelic or empathogenic properties. As a component of this partnership, MindMed and MindShift Compounds AG have agreed to develop next-gen psychedelic and empathogenic substances together. The first initial compounds have just been combined by MindShift Compounds AG and related patent applicati...

Read More
news image

PHARMACY MARKET

YANGTZE RIVER PHARMACEUTICAL GROUP SELECTS TRACELINK PLATFORM FOR GLOBAL COMPLIANCE

Yangtze River Pharmaceutical, TraceLink | May 06, 2021

TraceLink Inc., the leading digital network platform company, today announced that Yangtze River Pharmaceutical Group has selected TraceLink's global compliance solution to aid its plans for global growth. As the company gears up for international market expansion this year, Yangtze River Pharmaceutical Group (YRPG) will use TraceLink's multienterprise compliance applications and industry-leading digital supply network to comply with track and trace requirements in multiple markets, incl...

Read More
news image

CPD AND LEARNING

POSTERA AND NEUROLUCENT PARTNERS ON IDENTIFYING SMALL-MOLECULE THERAPEUTICS FOR ALZHEIMER'S DISEASE

PostEra | November 27, 2020

PostEra, a biotechnology organization offering restorative science fueled by AI, today reported a joint effort with NeuroLucent, a Chicago-put together organization centered with respect to creating novel medicines for Alzheimer's sickness and different dementias. The disappointment of late-stage clinical preliminaries to reveal viable treatments for Alzheimer's illness has underscored the need to investigate novel helpful methodologies. NeuroLucent is creating novel littl...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us